Breast cancer is a group of diseases that can develop in different tissues and cells of the breast. Although the term breast cancer describes a broad category, individual cancers can differ in their location, microscopic appearance, growth patterns, and biological characteristics. Understanding breast cancer types and characteristics can provide useful context for interpreting medical information and discussing diagnosis with qualified healthcare professionals. Breast cancer classification commonly considers whether abnormal cells remain within their original location or have invaded surrounding breast tissue.
Doctors may also classify tumors according to the cells or structures where they originate and based on biomarkers such as hormone receptor and HER2 status. These distinctions help describe the disease and may influence how clinicians evaluate and manage an individual diagnosis.
Breast cancer classification begins with identifying where abnormal cells originate and whether they have spread beyond their original location. The breast contains lobules, which produce milk, and ducts, which carry milk toward the nipple. Most breast cancers begin in cells lining these structures.
Noninvasive breast cancer types are cancers or abnormal cellular changes that remain confined to the area where they developed and have not invaded surrounding breast tissue. Ductal carcinoma in situ, commonly called DCIS, develops in the lining of the milk ducts. The abnormal cells remain within the ducts rather than extending into nearby breast tissue.
Lobular carcinoma in situ, or LCIS, is another condition involving abnormal cells in the lobules. LCIS is generally considered a marker of increased future breast cancer risk rather than an invasive cancer itself. Classic LCIS and pleomorphic LCIS can have different pathological features, making accurate classification important when interpreting a diagnosis.
Invasive breast cancer types have cells that have extended beyond the original structure into surrounding breast tissue. Invasive ductal carcinoma, also called invasive carcinoma of no special type, is the most frequently diagnosed invasive breast cancer. It begins in ductal cells and can extend into nearby breast tissue.
Invasive lobular carcinoma begins in the lobules and accounts for a smaller proportion of breast cancers. Its cells can grow in patterns that differ from invasive ductal carcinoma, which may affect how the tumor appears on imaging or under a microscope. Other less common invasive forms include tubular, mucinous, cribriform, and papillary carcinomas. These are classified according to their distinctive microscopic features.
Types of breast cancer can also be described according to the tissue involved, microscopic appearance, and biological markers. These classifications are not always mutually exclusive. For example, an invasive ductal carcinoma can also be classified according to its hormone receptor and HER2 status.
Ductal cancers originate from cells associated with the milk ducts, while lobular cancers arise from the lobules. Invasive ductal carcinoma is common among invasive breast cancers, whereas invasive lobular carcinoma has different cellular and growth characteristics.
The distinction between ductal and lobular disease is established through pathological examination. Tissue obtained through a biopsy can be examined by a pathologist to determine the cancer's cellular characteristics and classification.
Breast cancer tumor types also include several uncommon forms with characteristic microscopic patterns. Tubular carcinoma consists of small, well-formed tubular structures. Mucinous carcinoma contains tumor cells associated with substantial amounts of mucus-like material. Papillary carcinoma has a distinctive papillary growth pattern, while cribriform carcinoma contains cells arranged in sieve-like structures.
Medullary-like features can also occur in some breast cancers, although modern pathological classification has refined how these tumors are categorized. Metaplastic breast carcinoma represents another uncommon group in which cancer cells show differentiation toward cell types that are not typical of conventional breast tissue.
Breast cancer subtypes can also be defined by biological markers found on or within cancer cells. Three commonly evaluated markers are estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2, known as HER2.
Some breast cancers have receptors for estrogen, progesterone, or both. These cancers are generally described as hormone receptor-positive. Other tumors do not have these receptors and are classified as hormone receptor-negative.
Determining hormone receptor status requires laboratory testing of tissue obtained from the tumor. The results provide information about the biological characteristics of the cancer and are considered alongside other pathological findings.
HER2 is a protein involved in cell growth and signaling. Some breast cancers have higher-than-normal levels of HER2 or amplification of the HER2 gene. These tumors are classified as HER2-positive based on established testing criteria.
Other tumors do not show HER2 overexpression or gene amplification and are classified as HER2-negative. HER2 testing is therefore an important component of breast cancer classification.
Triple-negative breast cancer refers to tumors that lack estrogen receptors, progesterone receptors, and HER2 overexpression or amplification according to established testing standards. This category is defined by biomarker results rather than by a particular microscopic appearance.
Triple-negative tumors can include different pathological forms, so the term describes a biological classification rather than a single tumor type.
Breast cancer characteristics are evaluated using information from clinical examination, imaging, biopsy, and laboratory testing. Imaging methods such as mammography, ultrasound, and magnetic resonance imaging can provide information about the location and appearance of a breast abnormality, although imaging alone generally cannot establish the exact cancer type.
A biopsy provides tissue for microscopic examination. Pathologists can evaluate the arrangement and appearance of cells, the presence of invasion, and other features. The pathology report may describe tumor type, grade, receptor status, HER2 status, and other relevant findings.
Breast cancer classification also considers characteristics such as tumor grade and stage. Grade describes how closely cancer cells resemble normal cells and provides information about their microscopic appearance and biological behavior. It is different from stage, which describes the extent of cancer in the body.
Staging generally considers factors such as the size and local extent of the primary tumor, involvement of nearby lymph nodes, and whether cancer has spread to distant parts of the body. The combination of tumor type, grade, biomarkers, and stage provides a more complete description of an individual breast cancer diagnosis.
Understanding the different breast cancer types and characteristics helps distinguish between cancers that may appear similar clinically but differ biologically or microscopically. A diagnosis may therefore contain several classifications at the same time. For example, a pathology report might identify an invasive ductal carcinoma, provide a grade, and separately report estrogen receptor, progesterone receptor, and HER2 results.
Because breast cancer is a diverse group of diseases, terminology can sometimes be complex. The meaning of a specific classification depends on the complete pathology and clinical context rather than on the tumor name alone. Medical professionals use these combined findings to establish an individualized diagnosis and determine appropriate management considerations.